Nuvalent Inc vs BlackRock TCP Capital Corp — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while BlackRock TCP Capital Corp trades at $3.24 (market cap $270.17M). The key difference: Nuvalent Inc is far larger — about 36.3× BlackRock TCP Capital Corp's market cap, and BlackRock TCP Capital Corp pays a 26.09% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | TCPC | |
|---|---|---|
Market Cap | $9.81B | $270.17M |
Sector | Technology | Financials |
52-Week High | $123.96 | $7.64 |
52-Week Low | $72.16 | $3.14 |
Enterprise Value | $8.52B | — |
Dividend Yield | — | 26.09% |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →